Prevalence of sarcopenia and its association with functional and nutritional status among male residents in a nursing home in Turkey

Figures & data

Table I.  Demographic data, sarcopenia prevalence, functional status and nutritional status of the study cohort.

Age (year)	73.1 ± 6.7 (60–90)
Weight (kg)	67.0 ± 14.1 (38.9–105)
Height (cm)	162.2 ± 7.7 (145–181)
BMI (kg/m^2)	25.4 ± 5.0 (14.3–38.1)
No of chronic diseases	3.7 ± 1.8 (1–9)
No of drugs	7.5 ± 4.2 (0–18)
ADL score	8.9 ± 2.0 (2–10)
IADL score	8.7 ± 4.6 (0–14)

BMI, body mass index; ADL, activities of daily living; IADL, instrumental activities of daily living. Data are given as mean ± standard deviation (minimummaximum) when available.

Table II.  The comparison of fat free mass, ADL scores, IADL scores, MNA scores, number of chronic diseases and number of currently used drugs in sarcopenic versus non-sarcopenic residents.

	Sarcopenic residents (n = 134) (85.4%)	Non-sarcopenic residents (n = 23) (14.6%)	p
FFM (kg/BSA)	27.3 ± 1.6	30.7 ± 0.9	<0.0001*
ADL score	8.9 ± 2.0	8.7 ± 1.9	0.36
IADL score	8.7 ± 4.7	8.8 ± 4.3	0.94
MNA scores	18.1 ± 3.2	21.8 ± 0.8	0.02*

FFM, fat free mass; ADL, activities of daily living; IADL, instrumental activities of daily living; MNA, Mini Nutritional Assessment Test. Data are given as mean ± standard deviation.

*Statistically significant p values.